Sonia Maciá

Highlight Therapeutics

Sonia Maciá, MD, is an ESMO-certified Medical Oncologist. She obtained a master’s degree in Pharmacoeconomy in 2018 from Universitat Pompeu Fabra Barcelona and a PhD in Lung Cancer from the Department of Clinical Medicine, University Miguel Hernández. Dr. Maciá worked as a practicing Medical Oncologist for nine years and then decided to devote her career to clinical research. In 2012 she joined Pivotal SL, a European CRO, as Medical Manager, being thereafter promoted to Medical Director. After a few months in a similar role at ICON Plc, she joined Highlight Therapeutics to work on clinical development, providing medical support to clinical trials in solid tumors. Dr. Maciá has submitted more than forty abstracts to international congresses, published more than thirty papers in peer-reviewed journals, and authored six book chapters.

1books edited

1chapters authored

Latest work with IntechOpen by Sonia Maciá

Mesothelioma is an aggressive cancer with very poor survival and lack of treatment options. This book, written by a diverse panel of experts, presents a description of the most relevant topics on epidemiology, diagnosis, biomarkers, and treatment updates, including interesting discussion on molecular mechanisms, prognostic features, and novel therapies that are either approved or under clinical development for this challenging disease. It also discusses and explains genetic biomarkers, as there may be a role for some nuclear regulatory genes and proteins in development of mesothelioma, although targeted therapies so far have had limited impact.

Go to the book